Mizuho Securities Reiterates a Hold Rating on Mednax Inc (MD)

By Carrie Williams

In a report issued on November 2, Ann Hynes from Mizuho Securities reiterated a Hold rating on Mednax Inc (MD), with a price target of $43. The company’s shares closed on Friday at $39.24, close to its 52-week low of $37.26.

According to TipRanks.com, Hynes is a 3-star analyst with an average return of 3.0% and a 53.5% success rate. Hynes covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Acadia Healthcare, and Tenet Healthcare.

Currently, the analyst consensus on Mednax Inc is a Hold with an average price target of $46.83, which is a 19.3% upside from current levels. In a report issued on October 19, Robert W. Baird also maintained a Hold rating on the stock with a $48 price target.


See today’s analyst top recommended stocks >>

The company has a one-year high of $63.04 and a one-year low of $37.26. Currently, Mednax Inc has an average volume of 820K.

Based on the recent corporate insider activity of 35 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company’s solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting.